Home › Colon Cancer › New York
Colon Cancer clinical trials in New York
28 studies for Colon Cancer are looking for participants at sites in New York.
Cities in New York
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
- Montefiore Medical Center-Einstein Campus, The Bronx
- James J Peters VA Medical Center, The Bronx
RecruitingHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT07283939Family Communications After Genetic Testing
- Glens Falls Hospital, Glens Falls
RecruitingHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT07143487A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
- Memorial Sloan Kettering Cancer Center ( Site 0095), New York
- Ellis Hospital ( Site 0098), Schenectady
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT06997497Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
- NYOH Albany Cancer Center, Albany
- Hematology-Oncology Associates of Central New York, PC, Auburn
- North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, Babylon
- and 12 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07222800Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- Columbia University, New York
- NYU Langone Health, New York
- Memorial Sloan Kettering Cancer Center, New York
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06128551A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
- NYU Langone Health Perlmutter Cancer Center, New York
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT07629960A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
- Icahn School of Medicine At Mount Sinai, New York
- Memorial Sloan Kettering Cancer Center, New York
- Ny Cancer and Blood Specialists, Shirley
- and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT07284849Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
Recruiting
Ages 45 to 70 · All sexes · Updated Sep 2, 2026 · NCT05080673Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
- New York-Presbyterian/Brooklyn Methodist Hospital, Brooklyn
- The New York Hospital Medical Center of Queens, Flushing
- Glens Falls Hospital, Glens Falls
- and 23 more
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT05174169Shield Post-Approval Study Protocol
- Associated Gastroenterologists of Central New York, Camillus
- Syracuse Gastroenterological Associates, P.C., East Syracuse
- Associated Gastroenterologists of Central New York, Fayetteville
- and 4 more
RecruitingObservational studyHealthy volunteers welcome
Ages 45 to 81 · All sexes · Updated Aug 7, 2026 · NCT06880055Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
- Xencor Investigative Site, New York
- Xencor Investigative Site, New York
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 3, 2026 · NCT05433142A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
- Memorial Sloan Kettering Cancer Center - Investigational Drug Service Pharmacy, Long Island City
- Memorial Sloan Kettering Cancer Center - David H. Koch Center for Cancer Care (74th Street)., New York
- Memorial Sloan Kettering Cancer Center 53rd street., New York
- and 1 more
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jul 22, 2026 · NCT07318805EXoPERT EMERALD Clinical Study
- Albany Stratton VA Medical Center, Albany
- Bronx Veterans Medical Research Foundation, The Bronx
- VA Hudson Valley Healthcare System, Wappingers Falls
RecruitingObservational studyHealthy volunteers welcome
Ages 45 and older · All sexes · Updated Jul 1, 2026 · NCT07186296Integrated Cancer Repository for Cancer Research
- C.R. Wood Cancer Center, Glens Falls Hospital, Glens Falls
- Faxton St. Luke's Healthcare, Mohawk Valley, Utica
RecruitingObservational studyHealthy volunteers welcome
Ages 19 to 110 · All sexes · Updated Jun 29, 2026 · NCT02012699A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
- NYU Langone Medical Center, New York
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jun 12, 2026 · NCT06051695A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
- Research Site, New York
- Research Site, New York
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jun 10, 2026 · NCT06835569Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
- NYU Langone, New York
- Memorial Sloan Kettering Cancer Center, New York
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jun 3, 2026 · NCT06040541Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
- Perlmutter Cancer Center at NYU Langone Health, New York
- Memorial Sloan-Kettering Cancer Center, New York
- Columbia University, New York
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated May 15, 2026 · NCT05379985Brodalumab in the Treatment of Immune-Related Adverse Events
- Columbia University Irving Medical Center, New York
RecruitingPhase 1
Ages 18 and older · All sexes · Updated May 13, 2026 · NCT06673329Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers and Adenomas
- NYU Langone Health, New York
RecruitingObservational study
Ages 18 and older · All sexes · Updated May 11, 2026 · NCT00843375Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation
- Memorial Sloan Kettering Cancer Center, New York
RecruitingObservational study
Ages 18 and older · All sexes · Updated Mar 12, 2026 · NCT04668872Phase II Trial of Lung Chemoemobolization
- Memorial Sloan Kettering Cancer Center, New York
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Mar 5, 2026 · NCT05672108Stereotactic Ablative Radiotherapy (SABR) for the Treatment of Patients With Metastatic Cancer, ID-COMET Trial
- Roswell Park Comprehensive Cancer Center, Buffalo
RecruitingPhase 3
Ages 1 and older · All sexes · Updated Feb 4, 2026 · NCT06563388Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
- GSK Investigational Site, New York
- GSK Investigational Site, New York
- GSK Investigational Site, New York
- and 2 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jan 23, 2026 · NCT05855200Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
- Memorial Sloan Kettering Commack, Commack
- Memorial Sloan Kettering Westchester, Harrison
- Memorial Sloan Kettering Cancer Center, New York
- and 1 more
RecruitingObservational studyHealthy volunteers welcome
All ages · All sexes · Updated Jan 23, 2026 · NCT00582621Evaluation of Circulating Immune Response After Histosonics in Colorectal Cancer (ECHO-CRC)
- Zuckerberg Cancer Center, New Hyde Park
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jan 22, 2026 · NCT07361107SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Buffalo
- Massive Bio SYNERGY-AI site, Hempstead
- Massive Bio SYNERGY-AI site, Manhasset
- and 2 more
RecruitingObservational study
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
- NYU Langone Health, New York
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 9, 2025 · NCT06682793From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.